Skip to main content
Top
Published in: Critical Care 1/2004

01-02-2004 | Poster presentation

Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients

Authors: A Karabinis, M Malbrain, J Bakker, T Jensen, P Germann, D Breen, P Parkinson

Published in: Critical Care | Special Issue 1/2004

Login to get access

Excerpt

Remifentanil's titratability and rapid organ-independent metabolism make it ideally suited for use in critically ill patients. Establishing safety in this population is important as studies of remifentanil for greater than 3 days are limited. This study compared the safety and efficacy of remifentanil-based analgesia and sedation (RBA) with hypnotic-based sedation (HBS), in 105 ICU patients with medical conditions requiring long-term (up to 10 days) mechanical ventilation. …
Metadata
Title
Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
Authors
A Karabinis
M Malbrain
J Bakker
T Jensen
P Germann
D Breen
P Parkinson
Publication date
01-02-2004
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2704

Other articles of this Special Issue 1/2004

Critical Care 1/2004 Go to the issue